Cardiac sarcoidosis: Case presentation and Review of the literature.

Rom J Intern Med

Division of General Internal Medicine, Mayo Clinic, 4500 San Pablo, Rd, Jacksonville, FL32224, USA.

Published: March 2019

AI Article Synopsis

  • * When symptoms do appear, they tend to be vague and can sometimes lead to severe outcomes, making diagnosis difficult.
  • * Effective treatment focuses on managing inflammation and preventing heart damage, but the overall outlook for patients remains concerning, as shown in a case where initial symptoms did not lead to immediate diagnosis.

Article Abstract

Cardiac sarcoidosis usually occurs in the context of systemic disease; however, isolated cardiac involvement can occur in up to 25% of cases and tends to be clinically silent. When symptoms are present, they are often nonspecific and occasionally fatal, representing a diagnostic challenge. A high index of clinical suspicion and the integration of appropriate imaging, laboratory, and pathologic findings is always required. Treatment aims to control the systemic inflammatory condition while preventing further cardiac damage. However, even with adequate diagnosis and treatment strategies, prognosis remains poor. We describe the case of a patient who presented with cardiac symptoms, whose initial examination was unrevealing. Diagnosis was made retrospectively based on later systemic manifestations that revealed characteristic sarcoidosis findings.

Download full-text PDF

Source
http://dx.doi.org/10.2478/rjim-2018-0030DOI Listing

Publication Analysis

Top Keywords

cardiac sarcoidosis
8
cardiac
5
sarcoidosis case
4
case presentation
4
presentation review
4
review literature
4
literature cardiac
4
sarcoidosis occurs
4
occurs context
4
context systemic
4

Similar Publications

Purpose: The priorities and concerns of sarcoidosis patients in the United States (US) have not been well-described.

Methods: A survey constructed by sarcoidosis patients and doctors was administered to US sarcoidosis patients. The survey queried patients concerning their demographics, disease state, disease impact on health and well-being, health care priorities and impressions of sarcoidosis care.

View Article and Find Full Text PDF

Background: We compared long-term clinical outcomes between patients with cardiac sarcoidosis (CS) who received no treatment (NT), steroid treatment (ST), disease-modifying anti-rheumatic drugs (DMARDs), or tumor necrosis factor alpha inhibitors (TNF).

Methods: Patients from SSM healthcare system's data warehouse were identified using ICD codes. Inclusion criteria included at least 6 months of follow-up.

View Article and Find Full Text PDF

Background: Cardiac sarcoidosis (CS) is a chronic inflammatory disease characterised by non-caseating granulomas, while arrhythmogenic cardiomyopathy (ACM) is a genetic condition mainly affecting desmosomal proteins. The coexistence of CS and genetic variants associated with ACM is not well understood, creating challenges in diagnosis and management. This study aimed to describe the clinical, imaging and genetic features of patients with both conditions.

View Article and Find Full Text PDF

Background: Fibroblasts in the fibrotic heart exhibit a heterogeneous biological behavior. The specific subsets of fibroblasts that contribute to progressive cardiac fibrosis remain unrevealed. Our aim is to identify the heart fibroblast (FB) subsets that most significantly promote fibrosis and the related critical genes as biomarkers for ischemic heart disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!